Abstract:The incidence of the inferior vena cava (IVC) tumor thrombus is reported to be 4%-10% in patients with renal cell carcinoma (RCC). Tumor thrombus may extend through to the right atrium. Management of patients with level III/IV tumor thrombus is usually difficult. We report two cases of level IV thrombus in our hospital in 2002 and 2004. CASE REPORT Case 1 A 79-year-old man with edema of bilateral lower extremity for more than 20 days was admitted to our hospital on February 25, 2002. He was diagnosed as right RCC with IVC thrombus after ultrasonography and CT scan. MRI examination showed some occupying lesions in the liver. The renal tumor was about 4 cm in diameter and the upper limit of IVC thrombus reached the right atrium (Fig. 1A). Preoperative evaluation showed anemia (Hb 74.8 g/L) and hypoalbuminemia (29 g/L). AKP was high (312 U/L). Additional staging was made by chest X-ray examination and bone scan with no abnormalities. There was no other suspected distant metastasis. The patient underwent radical nephrectomy including lymphadenectomy and the tumor thrombus extirpation with extracorporeal bypass under the condition of hypothermia. The core temperature was 34°C. The abdomen was opened using a midline incision. After exploration of the abdomen to rule out metastatic disease, a median sternotomy was done and the pericardium was opened. Then mobilized the renal pedicle and ligated the renal artery. The kidney was mobilized out of Gerota's fascia. The thrombus with a solid cephalic head was difficult to be taken out completely from IVC (the vena caval wall was not involved). The right atrium was opened and the upper part of thrombus was taken out from the atrium and the lower part from the incision of the vena cava. Cardiovascular reconstruction was accomplished by direct suture. The duration was 330 minutes with 1500 ml blood loss. The patient had no perioperative complications. Pathological examination for the surgical specimens confirmed RCC along with the inferior vena caval thrombus. It also did not show any metastase in lymph nodes and adrenal gland. TNM staging was T3cN0M0. The patient has no recurrence or metastasis at the 49-month follow-up.Fig. 1.: MRI scan shows the right (A, case 1) and left (B, case 2) renal cell carcinoma with the V4 inferior vena cava thrombus.Case 2 A 40-year-old man with gross hematuria for 4 months was admitted to our hospital on July 7, 2004, without flank discomfort, fever or edema in lower extremity. The patient had a history of diabetes mellitus. Ultrasonography showed left renal tumor with invasion into IVC. Abdominal CT and MRI scans showed no abdominal visceral metastasis and the upper limit of IVC thrombus reached the right atrium (Fig. 1B). Chest X-ray film and AKP were normal. The patient also underwent radical nephrectomy including lymphadenectomy and the tumor thrombus extirpation with extracorporeal bypass. The abdomen was opened using a roof-shaped incision. The vena caval wall was not involved by the tumor thrombus. But the thrombus had a solid cephalic head (Fig. 2) which was difficult to be taken out completely from IVC. The right atrium was opened and the upper part of thrombus was taken out from the atrium and lower part from the incision of the vena cava. Cardiovascular reconstruction was accomplished by direct suture. The duration was 300 minutes with blood loss 2000 ml. This patient also had not perioperative complications. The pathology of surgical specimen showed RCC along with the inferior vena caval thrombus (Fig. 3). TNM staging was T3cN0M0. The patient recurred after 4 months under the diaphragm and underwent a second resection. Now he lives cancer-free for about 19 months.Fig. 2.: The thrombus was 20 cm long with a solid cephalic head (Case 2).Fig. 3.: The histological section of the inferior vena caval tumor thrombus (Case 2, HE staining, original magnification×400).DISCUSSION Vena caval tumor thrombus extension is a relatively uncommon event occurring in 4% to 10% of all patients with renal cell carcinoma.1–4 Among them, 2% to 27% have tumor thrombus extending into the right atrium.1,2,4,5 Historically, RCC with level III and IV thrombus (above the level of the liver) was deemed incurable. Considerable advances in the identification and management of thrombus including the use of new diagnostic imaging modalities to define the level of thrombus and the use of extracorporeal bypass, have permitted surgical resection of these complex thrombus possible. Symptoms of these patients are usually related to concomitant pulmonary emboli, renal or hepatic dysfunction or subtle physical signs including varicocele, dilated superficial abdominal veins or lower extremity edema. If there is suspicion of thrombus extension to the inferior vena cava, we proceed to MRI scan, which can reliably demonstrate a tumor thrombus and its extension, and also can rule out IVC wall invasion facilitating the exact surgical decision-making. Resection of RCC with tumor thrombus in IVC needs some technical considerations. ① To achieve optimal exposure, we use midline or chevron incision with a median sternotomy for level IV thrombus. ② Controlling the inferior vena cava above the thrombus to prevent cephalic mobilization of tumor fragment. This necessitates mobilization and isolation of the tributaries of the vena cava. ③ For atrial thrombus, the cardiopulmonary bypass allows the majority of these cases to be managed successfully. It should be kept in mind that digital manipulation of the tumor thrombus in an attempt to push it out from the IVC without the protection of cardiopulmonary bypass may be hazardous and may result in tumor embolism. There was few intraoperative complications occurred in our patients. This is in accordance with other reports. If treated without cardiopulmonary bypass, there would be a higher incidence of severe and unexpected bleeding or tumor embolization. Welz et al6 reported that no tumor embolization occurred in cardiopulmonary bypass group, whereas four (16%) occurred in the conventional technique group (P<0.05). Severe bleeding occurred in 11% of the cardiopulmonary bypass group and 16% in the conventional group. Perioperative mortality is high in patients with IVC thrombus. Sweeney et al7 reported 96 patients with complex IVC thrombi and the overall perioperative mortality was 5%. Among patients with level III/IV thrombi, they noted increased perioperative mortality (19%). Therefore there is little doubt that these patients present some of the most challenging oncological considerations. If these patients are not treated they have unfortunately poor survival rates.8 Some reports have shown that total resection of this tumor affords the best chance of cure and long-term survival when no distant metastases are present, the 5-year survival rates range between 40% and 69% after complete surgical resection.1–3,7 Both our patients have been alive for 19 and 49 months. It is in accordance with these reports. The prognostic factors of RCC with vena caval tumor thrombus extension are perinephric fat involvement, lymph node involvement, or distant metastases. If these findings are present, survival will be dismal. The prognostic significance of the tumor thrombus level in the IVC is still in controversy. Sosa et al9 reported a 2-year survival rate of 80% in patients with infrahepatic IVC tumor thrombi, while only 21% in those with suprahepatic thrombi. They found that patients with suprahepatic caval extension were more likely to have perinephric fat and regional lymph node involvement. Others found that in the absence of other adverse prognostic factors, the cephalic extension of IVC involvement did not appear to be prognostically important.7,10

Abstract:Respirology Case ReportsVolume 5, Issue 5 e00248 Case ReportOpen Access An intimal sarcoma of pulmonary artery mimicking pulmonary embolism: a case report and literature review Xiaojing Liu, Xiaojing Liu orcid.org/0000-0003-4778-8299 Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, China Department of Internal Medicine of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorJun Hou, Jun Hou Pathology Division of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorXiangdong Wang, Xiangdong Wang Research Center of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorZhihong Chen, Corresponding Author Zhihong Chen czh60@hotmail.com Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, China Correspondence Zhihong Chen, MD, PhD, Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Diseases, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. E-mail: czh60@hotmail.comSearch for more papers by this author Xiaojing Liu, Xiaojing Liu orcid.org/0000-0003-4778-8299 Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, China Department of Internal Medicine of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorJun Hou, Jun Hou Pathology Division of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorXiangdong Wang, Xiangdong Wang Research Center of Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorZhihong Chen, Corresponding Author Zhihong Chen czh60@hotmail.com Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, China Correspondence Zhihong Chen, MD, PhD, Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Diseases, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. E-mail: czh60@hotmail.comSearch for more papers by this author First published: 28 June 2017 https://doi.org/10.1002/rcr2.248Citations: 8 Associate Editor: Bei He AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Abstract Pulmonary artery intimal sarcoma is a highly aggressive disease, and is most often misdiagnosed as pulmonary thromboembolism (PTE) due to the similar clinical symptoms and its rarity, which leads to the use of inappropriate treatments such as prolonged anticoagulant therapy. We reported a case of pulmonary artery intimal sarcoma in a patient who was misdiagnosed as having PTE. Pathology after surgery confirmed malignant disease. We concluded that when a patient presents with mild clinical manifestations yet with strong imaging manifestations, pulmonary artery malignancy should be suspected. Introduction Pulmonary artery intimal sarcoma arises from the intimal layer of the right, left, or main pulmonary arteries 1. It is extremely rare, clinically unpredictable, and often misdiagnosed as pulmonary thromboembolism (PTE) because of the similar clinical presentation. Although the prognosis is poor, the misdiagnosis of pulmonary artery sarcoma may delay any possible treatment. In this study, we report a patient who was initially diagnosed with PTE but ultimately correctly diagnosed with pulmonary artery intimal sarcoma by pathology after surgical resection. Case Report A 63-year-old male presented to the emergency department of Zhongshan Hospital with complaints of right-sided chest pain for the past 2 weeks. The patient reported that the pain had increased gradually. He had mild chest congestion with mild cough and no haemoptysis, breathlessness, or fever. He had no hypoxaemia (partial pressure of oxygen (PaO2) 84 mmHg, peripheral capillary oxygen saturation (SpO2) 95%). Electrocardiogram (EKG) showed a left anterior fascicular block. Computerized tomography (CT) showed suspicious embolus in the right pulmonary artery. Computerized tomographic pulmonary angiography (CTPA) showed pulmonary embolism (PE) in the right pulmonary artery and upper right pulmonary artery and possible pulmonary infarction focally (Fig. 1A–D). D-dimer was 0.49 mg/L (normal range is 0.02–0.80 mg/L). Complete blood count (CBC), hepatic function, renal function, serum electrolytes, cardiac biomarkers, autoantibodies, and coagulation were normal. There was no internal bleeding. He was diagnosed with PE and was treated with low-molecular weight heparin (LMWH) for 2 weeks. Figure 1Open in figure viewerPowerPoint Series of images of computerized tomographic pulmonary angiography (CTPA) of the patient. (A–D) Images taken when the patient presented to hospital for the first time without any treatment. (E–H) Images taken 7 weeks after surgery and before chemotherapy. (I–L) Images taken after two cycles of chemotherapy. The patient was then transferred to the respiratory department for further treatment. D-dimer was monitored continuously and remained normal. Autoantibody, tumour markers, mycological examination, and T-spot were all normal. Relative examinations showed no deep vein thrombosis (DVT) on colour Doppler ultrasound and the echocardiography (echo) was normal (left ventricular ejection fraction (LVEF) 66%; all chambers of the heart and pulmonary artery pressure were normal; no thrombus echo was observed in the main pulmonary artery and the right and left branches of pulmonary artery). Considering all the atypical clinical manifestations, we suggested that the patient undergo a (18)F-positron emission tomography (PET)/CT, which revealed PE in the right pulmonary artery. The PET/CT also showed a mass originating from the endothelial cells in the right pulmonary artery (maximum standard uptake value (SUV) was 3.5). Meanwhile, there were multiple abnormal foci with high SUV in the right lung (maximum SUV was 7.9 and maximum diameter was 28.8 mm) (Fig. 2). Figure 2Open in figure viewerPowerPoint Images of (18)F-positron emission tomography (PET)/computerized tomography (CT) of the patient. After a cardiac surgery consultation, the tumour was resected. The patient received right pulmonary artery tumorectomy and pulmonary endarterectomy. During the surgery, we could see the right pulmonary artery was occupied by the tumour. Two arterial-wall-like tissues were sent for pathologic analysis. One mass, in which there was 4.5 × 2.5 × 2 cm large grey transparent sticky colloidal tissue, was 6.5 × 3.5 × 3 cm large and the wall was 0.3 cm thick. The other mass, with sticky colloidal tissue focally, was 3 × 2 × 1.5 cm large and the wall was 0.3 cm thick too. It was diagnosed as a spindle cell tumour that can be seen under an optical microscope. The immunological histological chemistry (IHC) results were S-100 (small amount +), α-smooth muscle actin (SMA; partial +), Desmin (Des) (−), CD34 (vascular +), CD31 (vascular +), Ki-67 (30% positive), F8 (vascular +), epithelial membrane antigen (EMA) (−), CKpan: a kind of immunohistochemical mark (CKPAN) (−), vimentin (VIM; +) (Fig. 3). Both the gross investigation and the IHC suggested intimal sarcoma. Then we examined the relevant gene mutation. Next-generation sequencing (NGS) showed gene mutations of CDK4, MDM2, FBXW7, FAT3, and FANCM. Figure 3Open in figure viewerPowerPoint Pathology of the tumour. (A) Haematoxylin and eosin (HE) stain of the tumour shows that the tumour arose from the intimal of pulmonary artery (50×). The black arrow indicates the neoplasm from the artery wall. (B) Microscopically, the tumour was composed of pleomorphic spindle cells (HE stain, 200×). (C) Tumour cells were immunohistochemically positive for α-smooth muscle actin (SMA). (D) Immunostaining for vimentin (VIM) highlights numerous neoplasm cells derived from mesenchymal tissue. The patient was followed-up closely after the surgery. Seven weeks after the surgery, the patient underwent CTPA examination again before he was started on chemotherapy. The second CTPA showed recurrence in the right pulmonary artery and the right upper pulmonary artery with nodular filling defect. Maximum metastasis seen was 6.3 cm in the right lung (Fig. 1E–H). The patient then agreed to receive chemotherapy the next day at our oncology department. The chemotherapy drug administered was epirubicin (90 mg/m2), for every 3 weeks. After two cycles of the chemotherapy, he underwent a third CTPA, which showed progress in the right pulmonary artery and the metastasis in the right lung (maximum diameter 9.7 cm) together with new lesions in the right lung and the right pleura (Fig. 1I–L). Afterwards, he was lost to follow-up. Discussion Intimal sarcoma is a totipotent-intimal-cell originated tumour. Pulmonary artery intimal sarcoma arises from the intimal layer of the right, left, or main pulmonary arteries, where pulmonary metastases are common 2. In extremely rare cases, it may extend in a retrograde manner to the pulmonary valve and right ventricle 1. Most cases of this disease are diagnosed on autopsy or with surgical specimens; therefore, the true incidence of intimal sarcoma of the pulmonary artery is unknown. The clinical presentation is often non-specific and related to tumour emboli. The most common symptoms are dyspnoea, tachypnoea, followed by chest or back pain, cough, haemoptysis, and malaise, which is quite similar to PTE. With such non-specific clinical features, the disease may mimic other diseases such as lung cancer, mediastinal masses, and especially acute or chronic PE 3, 4. Diagnosis in this patient was particularly difficult because of its long asymptomatic course and gradual development of symptoms of pulmonary hypertension and right heart failure 5. As for PTE, if the pulmonary trunk is occluded by a blood clot, the patient often presents rapid-onset dyspnoea and chest tightness with right ventricular dysfunction such as pulmonary artery dilation or pulmonary hypertension 6. However, the patient's chest pain developed gradually and no obvious shortness of breath was observed. The echo showed relatively normal heart function as well. D-dimer elevation is a sensitive indicator for thromboembolism either in lower limbs deep vein or pulmonary artery. D-dimer was normal for this patient from onset of the disease and during follow-up 7, 8. From the viewpoint of imaging, pulmonary artery intimal sarcoma and PTE are difficult to distinguish in the differential diagnosis. The presence of extraluminal tumour extension as well as distant metastases are reliable signs in the differential diagnosis, but these are manifestations of advanced cancer of intimal sarcoma 9. The CTPA demonstrates a filling defect, raising the suspicion of thromboembolism. Although both show enhancement on the CTPA, intimal sarcoma tends to present as a unilateral, central, lobulated, pulmonary artery filling defect with an increase in the diameter of the pulmonary arteries 3, 9-12 and acute angles with the vessel wall, in contrast to the PTE 13. And intimal sarcoma shows heterogeneous densities due to areas of necrosis, haemorrhage, and ossification within the mass 13. The PET/CT was used to confirm the suspicion of pulmonary artery intimal sarcoma and to distinguish with PTE on the basis of the increased radiopharmaceutical uptake of tumours 14, 15. The echo in these cases may reveal dilation of the right ventricle, with or without signs of obstruction of the right ventricular outflow tract or of the pulmonary trunk whereas PTE usually has right ventricular dysfunction such as right ventricular dilation, hypokinesis, or pressure overload 16, 17. The diagnosis of intimal sarcoma is usually made post-operatively or at autopsy, but PET/CT can be of great help. In our case, the patient had a subacute onset. His chief complaint was chest pain. The CTPA demonstrated an intraluminal filling defect occupying the entire lumen. The symptom and CTPA outcome indicated a type of vascular occlusion, such as PTE. But considering the mild clinical manifestation including the normal D-dimer and echo results, and the following PET/CT examination, prompted a diagnosis of pulmonary artery malignancy. It was manifested by pathology after surgery. Finally, we diagnosed pulmonary artery intimal sarcoma that originated from the right pulmonary artery with metastasis in the right lung. Knowledge about the molecular genetics and pathogenesis of intimal sarcoma is limited due to its rarity 18, 19. Intimal sarcomas are usually malignant mesenchymal tumours, which are poorly differentiated with fibroblastic or myofibroblastic differentiation 9. Pathologic diagnosis can be difficult because the intimal sarcoma does not express specific markers for immunohistochemistry 20. There are no specific guidelines for the management of patients with pulmonary artery intimal sarcoma 21. The rarity of this diagnosis made it difficult to standardize the therapy. Surgery is the mainstay of pulmonary artery intimal sarcoma. Reported curative surgical procedures for treating the tumour include tumour endarterectomy, graft reconstruction of the pulmonary artery, and pneumonectomy. Aggressively repeated surgical interventions of the primary tumour, local recurrence, and metastatic lesions were helpful to increase patient survival. The impact of chemotherapy and radiotherapy remains unclear, although some studies have demonstrated their effectiveness 2. The use of radiation therapy and chemotherapy after surgical treatment has been found to prolong survival time compared with surgery alone 3, 22, 23. Relative studies have shown that doxorubicin, and ifosfamide may be effective 24-27. Clinical trials to better understand the role of surgery, chemotherapy, and radiation therapy are difficult to carry out due to the rarity of the disease. The prognosis is also poor. In approximately 50% of the cases, pulmonary artery intimal sarcoma extends directly through the vessel wall to the adjacent lung, bronchial wall, lymph node, or heart. Distant metastases occur in 16–25% of the cases 28. It can metastasize to the brain, pancreas, adrenal glands, and lungs 21. The mean survival is 12–18 months 1, 29. Average survival at 5 years is less than 6% 30. Surgical resection has been reported to decrease clinical symptoms and lengthen survival 31-36. The prognosis seems to depend on the location and vascular extension 24. Death is usually due to right heart failure because of obstruction of the pulmonary arteries 30. In our case, the patient had mild chest pain with subacute onset, together with imaging that strongly suggested tumour involvement. His right pulmonary artery was totally blocked without any signs of heart failure or severe hypoxaemia and dyspnoea. Also, the D-dimer tests were always normal. Furthermore, the patient had metastasis in his right lung. And finally, he had no risk factors for PTE. All of the above observations were quite different from PTE as we know. Therefore we opted for PET/CT and the following treatment. To summarize, attention should be paid when the patient presents with mild clinical manifestations and severe imaging manifestations. Especially when the D-dimer is within the normal range and the presence of a low-density lobulated filling defect with uneven distribution and contrast enhancement in the entire luminal diameter on CTPA, pulmonary artery malignancy should be strongly suspected. The high uptake on PET/CT scan can prompt suspicion of the disease. In conclusion, untimely diagnosis leading to late stage presentations contributes to the poor prognosis of this disease. So early and proper diagnosis is necessary to establish appropriate therapy. Due to the high lethality of this tumour and the therapeutic and prognostic implications, it is of paramount importance for clinicians to be aware of the key features that differentiate this pathology from PTE. The PET/CT can be a proper way to help recognize intimal sarcomas when clinical manifestations are atypical. Given the dismal outcome and high risk of recurrence or metastatic spread of intimal sarcomas, the multimodal treatment, including a combinational treatment, appears justified. Difficulties in diagnosis and poor prognosis result in the lack of high volume studies and data registration, which means that further studies are necessary. Disclosure Statement No conflict of interest declared. Appropriate written informed consent was obtained for publication of this case report and accompanying images. Acknowledgments This work was supported by the National Natural Science Foundation of China (81270078, 81470211 by Z. Chen), the Shanghai 3 year Plan of the Key Subjects Construction in Public Health-Infectious Disease and Pathogenic Microorganism (15GWZK0102) and research fund from Shanghai Respiratory Research Institute. The authors would like to thank Yiqiu Zhang for providing the PET/CT figures. References 1 Ozbek C, Emrecan B, Calli AO, et al. 2007. Intimal sarcoma of the pulmonary artery with retrograde extension into the pulmonic valve and right ventricle. Tex. Heart Inst. J. 34(1): 119– 121. 2 Tanaka A, Shirasaka T, Okada K, et al. 2015. Aggressive multiple surgical interventions to pulmonary artery sarcoma. Eur. J. Cardiothorac. Surg. 47(2): 384– 385. 3 Cox JE, Chiles C, Aquino SL, et al. 1997. Pulmonary artery sarcomas: a review of clinical and radiologic features. J. Comput. Assist. Tomogr. 21(5): 750– 755. 4 Simpson WL Jr, and Mendelson DS. 2000. Pulmonary artery and aortic sarcomas: cross-sectional imaging. J. Thorac. Imaging 15(4): 290– 294. 5 Scheidl S, Taghavi S, Reiter U, et al. 2010. Intimal sarcoma of the pulmonary valve. Ann. Thorac. Surg. 89(4): e25– e27. 6 Miniati M, Cenci C, Monti S, et al. 2012. Clinical presentation of acute pulmonary embolism: survey of 800 cases. PLoS One 7(2): e30891. 7 Miniati M, Prediletto R, Formichi B, et al. 1999. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med. 159(3): 864– 871. 8 Stein PD, Beemath A, Matta F, et al. 2007. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am. J. Med. 120(10): 871– 879. 9 Attina D, Niro F, Tchouante P, et al. 2013. Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. Radiol. Med. 118(8): 1259– 1268. 10 Wittram C, Maher MM, Yoo AJ, et al. 2004. CT angiography of pulmonary embolism: diagnostic criteria and causes of misdiagnosis. Radiographics 24(5): 1219– 1238. 11 Castaner E, Gallardo X, Rimola J, et al. 2006. Congenital and acquired pulmonary artery anomalies in the adult: radiologic overview. Radiographics 26(2): 349– 371. 12 Kauczor HU, Schwickert HC, Mayer E, et al. 1994. Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc. Intervent. Radiol. 17(4): 185– 189. 13 Parish JM, Rosenow EC III, Swensen SJ, et al. 1996. Pulmonary artery sarcoma. Clinical features. Chest 110(6): 1480– 1488. 14 Ito K, Kubota K, Morooka M, et al. 2009. Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann. Nucl. Med. 23(7): 671– 676. 15 Chong S, Kim TS, Kim BT, et al. 2007. Pulmonary artery sarcoma mimicking pulmonary thromboembolism: integrated FDG PET/CT. AJR Am. J. Roentgenol. 188(6): 1691– 1693. 16 Austin BA, and Griffin BP. 2008. Pulmonary artery intimal sarcoma: a brief case series. J. Am. Soc. Echocardiogr. 21(8): 978.e975– 977. 17 Cohen AT, Dobromirski M, and Gurwith MM. 2014. Managing pulmonary embolism from presentation to extended treatment. Thromb. Res. 133(2): 139– 148. 18 Bode-Lesniewska B, Zhao J, Speel EJ, et al. 2001. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery. Virchows Arch. 438(1): 57– 65. 19 Zhang H, Macdonald WD, Erickson-Johnson M, et al. 2007. Cytogenetic and molecular cytogenetic findings of intimal sarcoma. Cancer Genet. Cytogenet. 179(2): 146– 149. 20 Burke AP, and Virmani R. 1993. Sarcomas of the great vessels. A clinicopathologic study. Cancer 71(5): 1761– 1773. 21 Yamamoto K, Nozue T, Tsuchida M, et al. 2012. Pulmonary embolism caused by intimal sarcoma of the pulmonary artery. Intern. Med. 51(21): 3031– 3034. 22 Genoni M, Biraima AM, Bode B, et al. 2001. Combined resection and adjuvant therapy improves prognosis of sarcomas of the pulmonary trunk. J. Cardiovasc. Surg. (Torino) 42(6): 829– 833. 23 Hirose T, Ishikawa N, Hamada K, et al. 2009. A case of intimal sarcoma of the pulmonary artery treated with chemoradiotherapy. Intern. Med. 48(4): 245– 249. 24 Hoiczyk M, Iliodromitis K, Bauer S, et al. 2012. Intimal sarcoma of the pulmonary artery with unusual findings: a case report. Clin. Res. Cardiol. 101(5): 397– 401. 25 Penel N, Taieb S, Ceugnart L, et al. 2008. Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapy. J. Thorac. Oncol. 3(8): 907– 911. 26 Head HD, Flam MS, John MJ, et al. 1992. Long-term palliation of pulmonary artery sarcoma by radical excision and adjuvant therapy. Ann. Thorac. Surg. 53(2): 332– 334. 27 Uchida A, Tabata M, Kiura K, et al. 2005. Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin. Jpn. J. Clin. Oncol. 35(7): 417– 419. 28 Chen X, Ren S, Li A, et al. 2014. A case report of chemo-sensitive intimal pulmonary artery sarcoma. Cell Biochem. Biophys. 68(1): 153– 157. 29 Huo L, Lai S, Gladish G, et al. 2005. Pulmonary artery angiosarcoma: a clinicopathologic and radiological correlation. Ann. Diagn. Pathol. 9(4): 209– 214. 30 Kojima K, Okamoto I, Ushijima S, et al. 2003. Successful treatment of primary pulmonary angiosarcoma. Chest 124(6): 2397– 2400. 31 Mattoo A, Fedullo PF, Kapelanski D, et al. 2002. Pulmonary artery sarcoma: a case report of surgical cure and 5-year follow-up. Chest 122(2): 745– 747. 32 Blackmon SH, Rice DC, Correa AM, et al. 2009. Management of primary pulmonary artery sarcomas. Ann. Thorac. Surg. 87(3): 977– 984. 33 Tucci M, Quatraro C, Calvani N, et al. 2005. Primary intimal sarcoma of the thoracic aorta. J. Exp. Clin. Cancer Res. 24(1): 139– 142. 34 Thalheimer A, Fein M, Geissinger E, et al. 2004. Intimal angiosarcoma of the aorta: report of a case and review of the literature. J. Vasc. Surg. 40(3): 548– 553. 35 Osei-Agyemang T, Geks J, Wagner HJ, et al. 2004. High-grade intimal sarcoma in an aneurysm of the infrarenal aorta. Chirurg 75(8): 823– 827. 36 Choi EY, Yoon YW, Kwon HM, et al. 2004. A case of pulmonary artery intimal sarcoma diagnosed with multislice CT scan with 3D reconstruction. Yonsei Med. J. 45(3): 547– 551. Citing Literature Volume5, Issue5September 2017e00248 FiguresReferencesRelatedInformation

Intimal Sarcoma of the Inferior Vena Cava with Extension to the Right Atrium, Bilateral Renal Vasculature, and Bilateral Venae Iliaca Communis, Accompanied by Severe Thrombocytopenia

A 10-Year Experience of Leiomyosarcoma of the Inferior Vena Cava.

One-stage surgery of low-grade malignant intravenous uterine leiomyosarcomatosis with right atrium extension.

Pulmonary Vein Sarcoma: a Case Report.

Renal Cell Carcinoma with Vena Caval Tumor Thrombus Extending into the Right Atrium.

Surgical management of complicated malignant tumor of the vena cava

Primary Angiosarcoma Of Inferior Vena Cava Extending To Right Atrium: A Case Report

[Diagnosis and Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus--a Report of 6 Cases with Literature Review].

Tislelizumab combined with GT chemotherapy for intimal sarcoma of inferior vena cava: A case report

Intravenous Leiomyomatosis with Intracardiac Extension:A Case Report

A case of left atrial intimal sarcoma with rhabdomyosarcoma differentiation: a case report and literature review

Surgical Treatments for Patients with Left Renal Carcinoma Associated with Inferior Vena Cava Tumor Thrombus

Unresectable leiomyosarcoma of the inferior vena cava with right atrium tumor thrombus: when to deem this tumor inoperable? A case report and literature review

An Intimal Sarcoma of Pulmonary Artery Mimicking Pulmonary Embolism: a Case Report and Literature Review

Resection of extensive segments of inferior vena cava without reconstruction in the treatment of renal carcinoma with inferior vena cava tumor thrombus: A case report

A case of a recurrent low-grade endometrial stromal sarcoma extending to the inferior vena cava (IVC) after the primary fertility-sparing surgery

A rare case of angiosarcoma with skull masses and erythropenia and thrombocytopenia: A case report and review of literature.

Case report: intravenous leiomyomatosis with intracaval and intracardiac growth

Resecting Lower Segment Inferior Vena Cava Leiomyosarcoma With Middle Segment Extension While Avoiding Renal Morbidity

Surgical and oncologic approach to leiomyosarcoma of the inferior vena cava: A case report

Surgical Treatment of Intravenous Leiomyomatosis with Inferior Vena Cava and Intracardiac Extension.